SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kush Andrew

(Last)

(First)

(Middle)

3220 TILLMAN DRIVE

SUITE 300

(Street)

BENSALEM

19020

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/11/2017

3. Issuer Name and Ticker or Trading Symbol
HEALTHCARE SERVICES GROUP INC [ HCSG ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	660	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Phantom Stock⁽¹⁾	⁽²⁾	⁽²⁾	Common Stock	1,820	$0.0	D
Restricted Stock	⁽³⁾	⁽³⁾	Common Stock	140	$0.0	D
Restricted Stock	⁽⁴⁾	⁽⁴⁾	Common Stock	375	$0.0	D
Restricted Stock	⁽⁵⁾	⁽⁵⁾	Common Stock	800	$0.0	D
Restricted Stock Units	⁽⁶⁾	⁽⁶⁾	Common Stock	8,500	$0.0	D
Stock Option (right to buy)	⁽⁷⁾	01/06/2021	Common Stock	2,000	$16.11	D
Stock Option (right to buy)	⁽⁷⁾	01/05/2022	Common Stock	5,000	$17.5	D
Stock Option (right to buy)	⁽⁸⁾	01/04/2023	Common Stock	5,000	$23.5	D
Stock Option (right to buy)	⁽⁹⁾	01/03/2024	Common Stock	5,000	$28.02	D
Stock Option (right to buy)	⁽¹⁰⁾	01/05/2025	Common Stock	5,000	$30.3	D
Stock Option (right to buy)	⁽¹¹⁾	01/04/2026	Common Stock	6,000	$34.14	D
Stock Option (right to buy)	⁽¹²⁾	01/04/2027	Common Stock	6,000	$39.38	D

Explanation of Responses:

1. Acquired pursuant to an Issuer contribution under the Healthcare Services Group, Inc. Deferred Compensation Plan.

2. Shares of Phantom Stock are payable in-kind following termination of the Reporting Person's employment with Issuer.

3. These Restricted Stock Awards shall vest at the rate of 20% annually, commencing on the first anniversary of the January 3, 2014 grant date, and as such, 210 of these awards have already vested.

4. These Restricted Stock Awards shall vest at the rate of 20% annually, commencing on the first anniversary of the January 5, 2015 grant date, and as such, 250 of these awards have already vested.

5. These Restricted Stock Awards shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2016 grant date, and as such, 200 of these awards have already vested.

6. These Restricted Stock Units shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2017 grant date.

7. These options have fully vested.

8. These options vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2013 grant date.

9. These options vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 3, 2014 grant date.

10. These options vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 5, 2015 grant date.

11. These options vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2016 grant date.

12. These options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2017 grant date.

Remarks:

	John C. Shea, by Power of Attorney	04/21/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.